Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001104659-25-010550

Options or other derivatives

  • Chief Executive Officer acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Birx Deborah Chief Executive Officer 2025-02-05 Grant or award · Stock Options (Right to Buy) +240,000 240,000 D
Loading xslF345X05/tm255864-1_4seq1.xml…